MAGRINI, STEFANO MARIA
 Distribuzione geografica
Continente #
NA - Nord America 13.989
EU - Europa 6.733
AS - Asia 3.303
Continente sconosciuto - Info sul continente non disponibili 23
AF - Africa 22
OC - Oceania 12
SA - Sud America 11
Totale 24.093
Nazione #
US - Stati Uniti d'America 13.961
UA - Ucraina 2.294
CN - Cina 2.265
DE - Germania 1.121
HK - Hong Kong 799
IT - Italia 789
IE - Irlanda 557
FI - Finlandia 525
PL - Polonia 486
FR - Francia 378
GB - Regno Unito 305
SE - Svezia 98
IN - India 81
BE - Belgio 74
VN - Vietnam 56
RU - Federazione Russa 46
TR - Turchia 37
CA - Canada 25
SG - Singapore 24
EU - Europa 23
NL - Olanda 18
GR - Grecia 12
AU - Australia 10
JP - Giappone 10
BR - Brasile 9
ID - Indonesia 6
IR - Iran 6
MU - Mauritius 6
CH - Svizzera 5
MA - Marocco 5
MK - Macedonia 4
UG - Uganda 4
IL - Israele 3
KR - Corea 3
TN - Tunisia 3
AR - Argentina 2
BD - Bangladesh 2
CZ - Repubblica Ceca 2
EG - Egitto 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
RO - Romania 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
TH - Thailandia 2
AM - Armenia 1
AT - Austria 1
BG - Bulgaria 1
BY - Bielorussia 1
DK - Danimarca 1
EE - Estonia 1
ES - Italia 1
HU - Ungheria 1
IS - Islanda 1
KW - Kuwait 1
LV - Lettonia 1
MX - Messico 1
MY - Malesia 1
NO - Norvegia 1
PT - Portogallo 1
RS - Serbia 1
SI - Slovenia 1
SL - Sierra Leone 1
ZA - Sudafrica 1
Totale 24.093
Città #
Jacksonville 1.777
Fairfield 1.744
Woodbridge 1.608
Houston 1.138
Ashburn 984
Ann Arbor 899
Princeton 806
Chandler 803
Hong Kong 794
Cambridge 772
Wilmington 696
Seattle 676
Nanjing 578
Dublin 554
Warsaw 486
New York 310
Beijing 301
Dearborn 268
Helsinki 218
Nanchang 217
Des Moines 178
Changsha 136
Shenyang 134
Hebei 125
Brescia 123
San Diego 120
Milan 119
Jinan 111
Tianjin 106
Jiaxing 88
Brussels 73
Shanghai 72
Kunming 63
Verona 58
Dong Ket 56
Hangzhou 50
Washington 46
London 41
Rome 40
Lancaster 36
Ningbo 32
Lanzhou 31
San Francisco 29
Taizhou 29
Zhengzhou 29
Norwalk 28
Augusta 24
Kocaeli 24
Haikou 22
Orange 22
Pune 22
Changchun 21
Guangzhou 20
Hanover 17
Boardman 16
Nürnberg 16
Taiyuan 16
Toronto 16
Ceto 15
Redwood City 14
Athens 12
Hefei 11
San Mateo 11
Chiswick 10
Dresden 10
Fuzhou 9
Gunzenhausen 8
Hounslow 8
Iseo 8
Kilburn 8
Tokyo 7
Amsterdam 6
Isorella 6
Monza 6
Mountain View 6
New Bedfont 6
Ardabil 5
Bologna 5
Cazzago San Martino 5
Chicago 5
Leawood 5
Rozzano 5
Bergamo 4
Berlin 4
Chongqing 4
Cremona 4
Delhi 4
Falkenstein 4
Falls Church 4
Florence 4
Frankfurt am Main 4
Lappeenranta 4
Melbourne 4
Palermo 4
Parma 4
Phoenix 4
Singapore 4
Sydney 4
Walnut 4
Wandsworth 4
Totale 18.081
Nome #
Low dose rate brachytherapy (LDR-BT) as monotherapy for early stage prostate cancer in Italy: practice and outcome analysis in a series of 2237 patients from 11 institutions 206
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: the Pros-IT CNR study 200
Light and shadows of a new technique: Isphoton total-skin irradiation using helical IMRT feasible, less complex and as toxic as the electrons one? 172
Biological effect of neoadjuvant androgen-deprivation therapy assessed on specimens from radical prostatectomy: a systematic review 161
Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study 155
From chemotherapy to target therapies associated with radiation in the treatment of NSCLC: a durable marriage? 153
Resected pN1 non-small cell lung cancer: recurrence patterns and nodal risk factors may suggest selection criteria for post-operative radiotherapy 150
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 148
Pros-IT CNR: an Italian prostate cancer monitoring project 145
Reirradiation in head and neck recurrent or second primary tumor: efficacy, safety, and prognostic factors 142
In reply to Borras et al. the strengthening of Radiation Oncologist role inside multidisciplinary arena within 2025 142
Post-surgical therapeutic approaches to glioblastoma patients submitted to biopsy (BA) or "partial" resection (PR): the possibilities to treat also them without renunciations. Study from the Brescia Neuro-Oncology Group 139
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Dental pathologies and osteoradionecrosis (Part 1) literature review and consensus statement 138
Cetuximab and Radiotherapy Versus Cisplatin and Radiotherapy for Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial 137
The treatment of patients with 1-3 brain metastases: is there a place for whole brain radiotherapy alone, yet? A retrospective analysis 136
Salvage therapy of small volume prostate cancer nodal failures: A review of the literature 134
THE ROLE OF PRIMARY SURGERY AND EXTERNAL BEAM RADIATION THERAPY IN THE MANAGEMENT OF NON-METASTATIC DUCTAL PROSTATE CANCER: 20-YEAR OUTCOMES FROM A SINGLE INSTITUTION EXPERIENCE 131
A neuro-oncologic challenge: the case of a large, aggressive, malignant meningioma of the skull base with paranasal sinus involvement 131
Reply to 'Comment on 'Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study'' 129
Clinical outcomes and toxicity after exclusive versus postoperative radiotherapy in supraglottic cancer: new solutions for old problems? The case of stage I and II disease 128
Subgroup Analysis According to Human Papillomavirus Status and Tumor Site of a Randomized Phase II Trial Comparing Cetuximab and Cisplatin Combined With Radiation Therapy for Locally Advanced Head and Neck Cancer 124
Clinical outcomes and toxicity after exclusive versus postoperative radiotherapy in supraglottic cancer: new solutions for old problems? The case of stage III and IV disease 122
Oligometastatic prostate cancer patients stratification: A molecular signature identified by liquid biopsy 122
Role of external beam radiotherapy in the treatment of relapsing meningioma 121
Patterns of practice and survival in a retrospective analysis of 1722 adult astrocytoma patients treated between 1985 and 2001 in 12 italian radiation oncology centers 120
Stereotactic ablative radiation therapy in renal cell carcinoma: From oligometastatic to localized disease. 118
Hypofractionated radiation therapy versus chemotherapy with temozolomide in patients affected by RPA class V and VI glioblastoma: a randomized phase II trial 117
Carboplatin (JM8), etoposide (VP16) and thoracic Irradiation for small cell lung cancer (S.C.L.C.): An evaluation of lung toxicity 116
Mebendazole as a candidate for drug repurposing in oncology: An extensive review of current literature 115
Primary cutaneous non-Hodgkin lymphoma: results of a retrospective analysis in the light of the recent ILROG guidelines 114
Non-palliative radiotherapy in ab initio oligometastatic prostate cancer: an Italian national survey 113
A benchmark study on 883 nasopharyngeal cancer patients treated in two Italian centres from 1977 to 2000. Part I: evolving technical choices and survival 112
Could Concomitant Radio-Chemotherapy Improve the Outcomes of Early-Stage Node Negative Anal Canal Cancer Patients? A Retrospective Analysis of 122 Patients 112
Clinical and histological prognostic factors of recurrent and/or metastatic salivary gland adenoid cystic carcinoma 112
Whole brain radiotherapy with adjuvant or concomitant boost in brain metastasis: dosimetric comparison between helical and volumetric IMRT technique 112
Effects of fluconazole in the prophylaxis of oropharyngeal candidiasis in patients undergoing radiotherapy for head and neck tumour: results from a double-blind placebo-controlled trial. 111
Radiotherapy for adult medulloblastoma: Long term result from a single institution. A review of prognostic factors and why we do need a multi-institutional cooperative program 111
Circulating tumor cells in patients with recurrent or metastatic head and neck carcinoma: prognostic and predictive significance 111
Adjuvant radiotherapy after extrapleural pneumonectomy for mesothelioma. Prospective analysis of a multi-institutional series 110
Adjuvant intensity-modulated proton therapy in malignant pleural mesothelioma 108
Predictive factors for oropharyngeal mycosis during radiochemotherapy for head and neck carcinoma and consequences on treatment duration. Results of mycosis in radiotherapy (MIR): A prospective longitudinal study 108
Could Machine Learning Improve the Prediction of Pelvic Nodal Status of Prostate Cancer Patients? Preliminary Results of a Pilot Study 107
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Xerostomia and trismus (Part 2). Literature review and consensus statement 107
Salvage Low Dose Rate Brachytherapy For Recurrent Prostate Cancer After External Beam Radiotherapy: Results From A Single Institution With Focus On Toxicity And Functional Outcomes 107
Extreme hypofractionation for early prostate cancer: Biology meets technology 107
Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer 106
Optimizing Radiation Treatment Decisions for Patients Who Receive Neoadjuvant Chemotherapy 106
Retreatment of recurrent adult medulloblastoma with radiotherapy: a case report and review of the literature. 106
Postoperative radiotherapy for prostate cancer: the sooner the better and potential to reduce toxicity even further 105
Circulating Tumour Cells in locally advanced head and neck cancer: Preliminary report about their possible role in predicting response to non-surgical treatment and survival. 104
Changes in patterns of practice for prostate cancer radiotherapy in Italy 1995-2003. A survey of the Prostate Cancer Study Group of the Italian Radiation Oncology Society 104
Pattern of relapse of glioblastoma multiforme treated with radical radio-chemotherapy: Could a margin reduction be proposed? 104
Radiation Tolerance of Normal Brain: QUANTEC 2010 and Beyond 104
Exploiting Machine Learning for Predicting Nodal Status in Prostate Cancer Patients 103
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study 102
From Molecular to Clinical Radiation Biology of Glioblastoma 101
Glutamine synthetase expression as a valuable marker of epilepsy and longer survival in newly diagnosed glioblastoma multiforme 101
Open-source, low cost, high-reliability solutions for digital imaging systrems: example of a dicom router/Soluzioni Open Source per sistemi Low Cost e High Reliability per l'imaging digitale: l'esempio di un dicom router. 100
Radiotherapy in Small Cell Lung Cancer 98
Radiotherapy and Tyrosine Kinase Inhibitors in Stage IV Non-small Cell Lung Cancer: Real-life Experience 98
Analysis of Circulating Tumor Cells in Prostate Cancer Patients at PSA Recurrence and Review of the Literature 98
Which role for radiation therapy in ethmoid cancer? A retrospective analysis of 84 cases from a single Institution 97
Association between testicular cancer and spina bifida occulta 97
A benchmark study on 883 nasopharyngeal cancer patients treated in two Italian centres from 1977 to 2000. Part II: evolving technical choices and toxicity patterns 95
Stereotactic body radiotherapy for lung oligometastases impacts on systemic treatment-free survival: a cohort study 95
Merkel Cell Carcinoma: Report of Two Cases and Clinical Considerations 92
Interim PET After Two ABVD Cycles in Early-Stage Hodgkin Lymphoma: Outcomes Following the Continuation of Chemotherapy Plus Radiotherapy 92
Nasopharyngeal carcinoma 91
Radioterapia ("extended field") versus chemioterapia (MOPP) nel trattamento del m.di Hodgkin (stadio patologico I-IIA): risultati a 10 anni di uno studio prospettico randomizzato italiano 91
Information Retrieval in Medicine: an Extensive Experimental Study 91
The growing role of biology in the treatment of glioblastoma: no more one kind of disease 91
Differential Diagnosis and Clinical Management of a Case of COVID-19 in a Patient With Stage III Lung Cancer Treated With Radio-chemotherapy and Durvalumab 91
In haematopoietic SCT for acute leukemia TBI impacts on relapse but not survival: results of a multicentre observational study. 90
Cetuximab and Radiation Therapy in Head and Neck Cancer 90
The impact of the histology of primary tumor on RPA prognostic classifications in patients (pts) treated for brain metastases (BM). Retrospective analysis of 382 pts treated with hypofractionated whole brain radiotherapy (HWBRT). 89
Radiotherapy in low-grade glioma adult patients: a retrospective survival and neurocognitive toxicity analysis. 89
Exploring the role of enzalutamide in combination with radiation therapy: An in vitro study 89
Radical radiotherapy of bladder cancer retrospective analysis of a series of 459 patients treated in an Italian Institution 88
Limited-stage small-cell lung cancer treated with early chemo-radiotherapy: the impact of effective chemotherapy. 88
Reliability of prostate-specific antigen-marker in determining biochemical failure during the first 2 years after external beam radiation therapy and hormone therapy in patients with non-operated prostate cancer. 88
GUROPA survey: genito-urinary radiation oncology prescription attitudes 88
COVID-19 Outbreak and Cancer Radiotherapy Disruption in Lombardy, Northern Italy 88
The risk of second malignant tumors and its consequences for the overall survival of Hodgkin's disease patients and for the choice of their treatment at presentation: analysis of a series of 1524 cases consecutively treated at the Florence University Hospital 87
Gene expression profiling to improve prognostic characterization of olfactory neuroblastoma and to define new targetable pathways 87
Late computed tomography scan response improvement and gallium scintigraphy evaluation as on-treatment prognostic parameters to tailor treatment intensity in patients with Hodgkin's lymphoma. A prospective phase II study. 86
The updated ESTRO core curricula 2011 for clinicians, medical physicists and RTTs in radiotherapy/radiation oncology. 86
Consensus statements on ablative radiotherapy for oligometastatic prostate cancer: A position paper of Italian Association of Radiotherapy and Clinical Oncology (AIRO) 86
Long term nervous system damage from radiation of the spinal cord: an electrophysiological study 85
Chordoma- Natural history, treatment and prognosis. The Florence Radiotherapy Department experience and a critical review of the literature 85
Radical radiotherapy for bladder cancer: retrospective analysis of a series of 459 patients treated in an Italian institution. 85
Combination of novel systemic agents and radiotherapy for solid tumors – part I: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment efficacy 85
"CHEMOTHERAPY VERSUS RADIOTHERAPY IN EARLY-STAGE HODGKIN'S DISEASE: EVIDENCE OF A MORE DIFFICULT RESCUE FOR PATIENTS RELAPSED AFTER CHEMOTHERAPY" 84
Comparison of the conventional "box" technique with two different "conformal" beam arrangements for prostate cancer treatment 84
Radical radiotherapy for early glottic cancer: Results in a series of 1087 patients from two Italian radiation oncology centers. II. The case of T2N0 disease. 84
Duration of androgen suppression in the treatment of prostate cancer 84
Results of radiotherapy of prostate cancer: the Florence experience 84
Radiotherapy in case of locally advanced prostate cancer: long-term follow-up in 223 patients 84
Survival and toxicity of radical radiotherapy (with or without brachytherapy) for FIGO stage I and II cervical cancer: a mono-institutional analysis. 83
Localized extranodal lymphoma of the head and neck: retrospective analysis of a series of 107 patients from a single institution. 82
Two months of radiation oncology in the heart of Italian “red zone” during COVID-19 pandemic: paving a safe path over thin ice 82
Totale 10.887
Categoria #
all - tutte 111.180
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 111.180


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.082 0 0 0 0 0 0 0 0 25 229 450 378
2019/20206.593 1.064 162 179 688 276 816 589 770 383 1.011 185 470
2020/20214.868 82 527 171 578 187 635 130 584 781 470 523 200
2021/20222.644 143 488 47 104 44 137 113 211 155 305 229 668
2022/20232.549 449 133 72 160 173 638 14 241 313 168 100 88
2023/20242.279 137 51 262 140 127 529 91 116 826 0 0 0
Totale 24.597